A citation-based method for searching scientific literature

Satoshi Deyama, Eunyoung Bang, Taro Kato, Xiao-Yuan Li, Ronald S Duman. Biol Psychiatry 2019
Times Cited: 49







List of co-cited articles
472 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Role of Neuronal VEGF Signaling in the Prefrontal Cortex in the Rapid Antidepressant Effects of Ketamine.
Satoshi Deyama, Eunyoung Bang, Eric S Wohleb, Xiao-Yuan Li, Taro Kato, Danielle M Gerhard, Sophie Dutheil, Jason M Dwyer, Seth R Taylor, Marina R Picciotto,[...]. Am J Psychiatry 2019
47
42

mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists.
Nanxin Li, Boyoung Lee, Rong-Jian Liu, Mounira Banasr, Jason M Dwyer, Masaaki Iwata, Xiao-Yuan Li, George Aghajanian, Ronald S Duman. Science 2010
38

Antidepressant effects of ketamine in depressed patients.
R M Berman, A Cappiello, A Anand, D A Oren, G R Heninger, D S Charney, J H Krystal. Biol Psychiatry 2000
32

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Carlos A Zarate, Jaskaran B Singh, Paul J Carlson, Nancy E Brutsche, Rezvan Ameli, David A Luckenbaugh, Dennis S Charney, Husseini K Manji. Arch Gen Psychiatry 2006
32

NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses.
Anita E Autry, Megumi Adachi, Elena Nosyreva, Elisa S Na, Maarten F Los, Peng-fei Cheng, Ege T Kavalali, Lisa M Monteggia. Nature 2011
26

BDNF release is required for the behavioral actions of ketamine.
Ashley E Lepack, Manabu Fuchikami, Jason M Dwyer, Mounira Banasr, Ronald S Duman. Int J Neuropsychopharmacol 2014
230
24

A neurotrophic model for stress-related mood disorders.
Ronald S Duman, Lisa M Monteggia. Biol Psychiatry 2006
22

Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure.
Nanxin Li, Rong-Jian Liu, Jason M Dwyer, Mounira Banasr, Boyoung Lee, Hyeon Son, Xiao-Yuan Li, George Aghajanian, Ronald S Duman. Biol Psychiatry 2011
746
20

Activity-dependent brain-derived neurotrophic factor signaling is required for the antidepressant actions of (2R,6R)-hydroxynorketamine.
Kenichi Fukumoto, Manoela V Fogaça, Rong-Jian Liu, Catharine Duman, Taro Kato, Xiao-Yuan Li, Ronald S Duman. Proc Natl Acad Sci U S A 2019
94
18

Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice.
Madhukar H Trivedi, A John Rush, Stephen R Wisniewski, Andrew A Nierenberg, Diane Warden, Louise Ritz, Grayson Norquist, Robert H Howland, Barry Lebowitz, Patrick J McGrath,[...]. Am J Psychiatry 2006
18

R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects.
C Yang, Y Shirayama, J-c Zhang, Q Ren, W Yao, M Ma, C Dong, K Hashimoto. Transl Psychiatry 2015
332
18

VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants.
Jennifer L Warner-Schmidt, Ronald S Duman. Proc Natl Acad Sci U S A 2007
339
18

Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants.
Ronald S Duman, George K Aghajanian, Gerard Sanacora, John H Krystal. Nat Med 2016
742
18

Brain-derived neurotrophic factor Val66Met allele impairs basal and ketamine-stimulated synaptogenesis in prefrontal cortex.
Rong-Jian Liu, Francis S Lee, Xiao-Yuan Li, Francis Bambico, Ronald S Duman, George K Aghajanian. Biol Psychiatry 2012
273
18

Vascular endothelial growth factor signaling is required for the behavioral actions of antidepressant treatment: pharmacological and cellular characterization.
Joshua Greene, Mounira Banasr, Boyoung Lee, Jennifer Warner-Schmidt, Ronald S Duman. Neuropsychopharmacology 2009
121
18


NMDAR inhibition-independent antidepressant actions of ketamine metabolites.
Panos Zanos, Ruin Moaddel, Patrick J Morris, Polymnia Georgiou, Jonathan Fischell, Greg I Elmer, Manickavasagom Alkondon, Peixiong Yuan, Heather J Pribut, Nagendra S Singh,[...]. Nature 2016
860
16


The Effect of a Single Dose of Intravenous Ketamine on Suicidal Ideation: A Systematic Review and Individual Participant Data Meta-Analysis.
Samuel T Wilkinson, Elizabeth D Ballard, Michael H Bloch, Sanjay J Mathew, James W Murrough, Adriana Feder, Peter Sos, Gang Wang, Carlos A Zarate, Gerard Sanacora. Am J Psychiatry 2018
301
14


A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression.
Nancy Diazgranados, Lobna Ibrahim, Nancy E Brutsche, Andrew Newberg, Phillip Kronstein, Sami Khalife, William A Kammerer, Zenaide Quezado, David A Luckenbaugh, Giacomo Salvadore,[...]. Arch Gen Psychiatry 2010
668
14

Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors.
Sungho Maeng, Carlos A Zarate, Jing Du, Robert J Schloesser, Joseph McCammon, Guang Chen, Husseini K Manji. Biol Psychiatry 2008
839
14

Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial.
Carlos A Zarate, Nancy E Brutsche, Lobna Ibrahim, Jose Franco-Chaves, Nancy Diazgranados, Anibal Cravchik, Jessica Selter, Craig A Marquardt, Victoria Liberty, David A Luckenbaugh. Biol Psychiatry 2012
511
12

Synaptic dysfunction in depression: potential therapeutic targets.
Ronald S Duman, George K Aghajanian. Science 2012
799
12

BDNF release and signaling are required for the antidepressant actions of GLYX-13.
T Kato, M V Fogaça, S Deyama, X-Y Li, K Fukumoto, R S Duman. Mol Psychiatry 2018
55
12

Scopolamine rapidly increases mammalian target of rapamycin complex 1 signaling, synaptogenesis, and antidepressant behavioral responses.
Bhavya Voleti, Andrea Navarria, Rong-Jian Liu, Mounira Banasr, Nanxin Li, Rose Terwilliger, Gerard Sanacora, Tore Eid, George Aghajanian, Ronald S Duman. Biol Psychiatry 2013
189
12

Fast-acting antidepressants rapidly stimulate ERK signaling and BDNF release in primary neuronal cultures.
Ashley E Lepack, Eunyoung Bang, Boyoung Lee, Jason M Dwyer, Ronald S Duman. Neuropharmacology 2016
101
12

VEGF links hippocampal activity with neurogenesis, learning and memory.
Lei Cao, Xiangyang Jiao, David S Zuzga, Yuhong Liu, Dahna M Fong, Deborah Young, Matthew J During. Nat Genet 2004
612
12

Sestrin modulator NV-5138 produces rapid antidepressant effects via direct mTORC1 activation.
Taro Kato, Santosh Pothula, Rong-Jian Liu, Catharine H Duman, Rosemarie Terwilliger, George P Vlasuk, Eddine Saiah, Seung Hahm, Ronald S Duman. J Clin Invest 2019
41
14

The economic burden of adults with major depressive disorder in the United States (2005 and 2010).
Paul E Greenberg, Andree-Anne Fournier, Tammy Sisitsky, Crystal T Pike, Ronald C Kessler. J Clin Psychiatry 2015
901
12

GABA interneurons are the cellular trigger for ketamine's rapid antidepressant actions.
Danielle M Gerhard, Santosh Pothula, Rong-Jian Liu, Min Wu, Xiao-Yuan Li, Matthew J Girgenti, Seth R Taylor, Catharine H Duman, Eric Delpire, Marina Picciotto,[...]. J Clin Invest 2020
108
12

Resolvin D1 and D2 Reverse Lipopolysaccharide-Induced Depression-Like Behaviors Through the mTORC1 Signaling Pathway.
Satoshi Deyama, Yuka Ishikawa, Kotomi Yoshikawa, Kento Shimoda, Soichiro Ide, Masamichi Satoh, Masabumi Minami. Int J Neuropsychopharmacol 2017
55
12

Rapid and longer-term antidepressant effects of repeated-dose intravenous ketamine for patients with unipolar and bipolar depression.
Wei Zheng, Yan-Ling Zhou, Wei-Jian Liu, Cheng-Yu Wang, Yan-Ni Zhan, Han-Qiu Li, Li-Jian Chen, Ming Ding Li, Yu-Ping Ning. J Psychiatr Res 2018
74
10

Dose-Related Effects of Adjunctive Ketamine in Taiwanese Patients with Treatment-Resistant Depression.
Tung-Ping Su, Mu-Hong Chen, Cheng-Ta Li, Wei-Chen Lin, Chen-Jee Hong, Ralitza Gueorguieva, Pei-Chi Tu, Ya-Mei Bai, Chih-Ming Cheng, John H Krystal. Neuropsychopharmacology 2017
105
10

GSK-3 inhibition potentiates the synaptogenic and antidepressant-like effects of subthreshold doses of ketamine.
Rong-Jian Liu, Manabu Fuchikami, Jason M Dwyer, Ashley E Lepack, Ronald S Duman, George K Aghajanian. Neuropsychopharmacology 2013
171
10

Side-effects associated with ketamine use in depression: a systematic review.
Brooke Short, Joanna Fong, Veronica Galvez, William Shelker, Colleen K Loo. Lancet Psychiatry 2018
211
10

Brain-derived neurotrophic factor Val66Met polymorphism and antidepressant efficacy of ketamine in depressed patients.
Gonzalo Laje, Níall Lally, Daniel Mathews, Nancy Brutsche, Anat Chemerinski, Nirmala Akula, Benjamin Kelmendi, Arthur Simen, Francis J McMahon, Gerard Sanacora,[...]. Biol Psychiatry 2012
141
10

A meta-analysis of cytokines in major depression.
Yekta Dowlati, Nathan Herrmann, Walter Swardfager, Helena Liu, Lauren Sham, Elyse K Reim, Krista L Lanctôt. Biol Psychiatry 2010
10

Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress.
Olivier Berton, Colleen A McClung, Ralph J Dileone, Vaishnav Krishnan, William Renthal, Scott J Russo, Danielle Graham, Nadia M Tsankova, Carlos A Bolanos, Maribel Rios,[...]. Science 2006
10

Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior.
Zhe-Yu Chen, Deqiang Jing, Kevin G Bath, Alessandro Ieraci, Tanvir Khan, Chia-Jen Siao, Daniel G Herrera, Miklos Toth, Chingwen Yang, Bruce S McEwen,[...]. Science 2006
963
10

Decreased expression of synapse-related genes and loss of synapses in major depressive disorder.
Hyo Jung Kang, Bhavya Voleti, Tibor Hajszan, Grazyna Rajkowska, Craig A Stockmeier, Pawel Licznerski, Ashley Lepack, Mahesh S Majik, Lak Shin Jeong, Mounira Banasr,[...]. Nat Med 2012
458
10

Activity-Dependent Brain-Derived Neurotrophic Factor Release Is Required for the Rapid Antidepressant Actions of Scopolamine.
Sriparna Ghosal, Eunyoung Bang, Wenzhu Yue, Brendan D Hare, Ashley E Lepack, Matthew J Girgenti, Ronald S Duman. Biol Psychiatry 2018
70
10

Low vascular endothelial growth factor and interleukin-8 in cerebrospinal fluid of suicide attempters.
J Isung, S Aeinehband, F Mobarrez, B Mårtensson, P Nordström, M Asberg, F Piehl, J Jokinen. Transl Psychiatry 2012
60
10

Sustained rescue of prefrontal circuit dysfunction by antidepressant-induced spine formation.
R N Moda-Sava, M H Murdock, P K Parekh, R N Fetcho, B S Huang, T N Huynh, J Witztum, D C Shaver, D L Rosenthal, E J Alway,[...]. Science 2019
243
10

GABA interneurons mediate the rapid antidepressant-like effects of scopolamine.
Eric S Wohleb, Min Wu, Danielle M Gerhard, Seth R Taylor, Marina R Picciotto, Meenakshi Alreja, Ronald S Duman. J Clin Invest 2016
87
10

The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function.
Michael F Egan, Masami Kojima, Joseph H Callicott, Terry E Goldberg, Bhaskar S Kolachana, Alessandro Bertolino, Eugene Zaitsev, Bert Gold, David Goldman, Michael Dean,[...]. Cell 2003
10

Anti-anhedonic effect of ketamine and its neural correlates in treatment-resistant bipolar depression.
N Lally, A C Nugent, D A Luckenbaugh, R Ameli, J P Roiser, C A Zarate. Transl Psychiatry 2014
158
10

Resolvin E1/E2 ameliorate lipopolysaccharide-induced depression-like behaviors via ChemR23.
Satoshi Deyama, Kento Shimoda, Hiroe Suzuki, Yuka Ishikawa, Kohei Ishimura, Hayato Fukuda, Natsuko Hitora-Imamura, Soichiro Ide, Masamichi Satoh, Katsuyuki Kaneda,[...]. Psychopharmacology (Berl) 2018
39
12

Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression.
Marion J F Levy, Fabien Boulle, Harry W Steinbusch, Daniël L A van den Hove, Gunter Kenis, Laurence Lanfumey. Psychopharmacology (Berl) 2018
107
10

VEGF and depression: a comprehensive assessment of clinical data.
Anne Clark-Raymond, Angelos Halaris. J Psychiatr Res 2013
65
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.